GW gains on first sales figure for Epidiolex

GW Pharmaceuticals plc (NASDAQ:GWPH) added $21.10 (14%) to $173.99 on Feb. 27 after reporting that sales of

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE